SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-022556
Filing Date
2017-04-27
Accepted
2017-04-27 14:02:55
Documents
3
Period of Report
2017-04-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v465280_8k.htm 8-K 21583
2 EXHIBIT 99.1 v465280_ex99-1.htm EX-99.1 8677
3 GRAPHIC s1.jpg GRAPHIC 52185
  Complete submission text file 0001144204-17-022556.txt   103432
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 17787944
SIC: 2834 Pharmaceutical Preparations